A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53
A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53
批准号:
7719057
负责人:
JOHN L. MARSHALL
金额:
$0.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2009-03-31
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这项研究的主要目的是评估在5周的疗程中递增剂量SGT-53的安全性。安全性将通过不良反应分析、临床实验室测试和体检进行评估。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The primary objective of this study is to evaluate the safety of escalating doses of SGT-53 administered over a course of 5 weeks. Safety will be assessed by analysis of adverse experiences, clinical laboratory tests, and physical examinations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY
-
批准号:7951970
-
项目类别:
-
资助金额:$2.42万
-
财政年份:2009
-
负责人:JOHN L. MARSHALL
-
依托单位:
CLINICAL TRIAL: PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY
-
批准号:7719032
-
项目类别:
-
资助金额:$9.92万
-
财政年份:2008
-
负责人:JOHN L. MARSHALL
-
依托单位:
VACCINIA-CEA(6D)TRICOM & FOWLPOX-CEA(6D)-TAXOTERE W/GM-CSF & DOCETAXEL
-
批准号:7608454
-
项目类别:
-
资助金额:$10.51万
-
财政年份:2007
-
负责人:JOHN L. MARSHALL
-
依托单位:
PH I: ORAL GLEEVEC & ONE HR WEEKLY PACLITAXEL INFUSION- METASTATICS SOLID TUMORS
-
批准号:7608455
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2007
-
负责人:JOHN L. MARSHALL
-
依托单位:
TRICOM + TAXOTERE
-
批准号:7608288
-
项目类别:
-
资助金额:$1.08万
-
财政年份:2006
-
负责人:JOHN L. MARSHALL
-
依托单位:
PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY PACLITAXEL IN
-
批准号:7608292
-
项目类别:
-
资助金额:$1.43万
-
财政年份:2006
-
负责人:JOHN L. MARSHALL
-
依托单位:
PHASE I CLINICAL TRIAL OF DAILY ORAL GLEEVEC (IMATINIB MESYLATE)
-
批准号:7199728
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2005
-
负责人:JOHN L. MARSHALL
-
依托单位:
PHASE III: CHEMORADIATN AFTER GASTRIC RESECTN OR GASTROESOPHAGEAL ADENOCARCINOMA
-
批准号:7199729
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2005
-
负责人:JOHN L. MARSHALL
-
依托单位:
TRICOM + TAXOTERE
-
批准号:7376124
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2005
-
负责人:JOHN L. MARSHALL
-
依托单位:
PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY PACLITAXEL IN
-
批准号:7376130
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2005
-
负责人:JOHN L. MARSHALL
-
依托单位:
CALGB 89903: PH II OF ANTI-IDIOTYPE MONOCLONALANTIBODY VACCINE CEAVAC & TRIAB
-
批准号:7199727
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2005
-
负责人:JOHN L. MARSHALL
-
依托单位:
Daily oral Gleevec and 1hr weekly Paclitaxel infusion
-
批准号:6982444
-
项目类别:
-
资助金额:$6.81万
-
财政年份:2002
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY IN PATIENTS WITH ADVANCED CA
-
批准号:6489400
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY IN PATIENTS WITH ADVANCED CA
-
批准号:6626776
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY IN PATIENTS WITH ADVANCED CA
-
批准号:6226323
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2001
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY IN PATIENTS WITH ADVANCED CA
-
批准号:6696733
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY IN PATIENTS WITH ADVANCED CA
-
批准号:6841155
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2001
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY OF CEA BEARING TUMORS
-
批准号:2896784
-
项目类别:
-
资助金额:$7.82万
-
财政年份:1998
-
负责人:JOHN L. MARSHALL
-
依托单位:
CEA BASED VACCINE THERAPY OF CEA BEARING TUMORS
-
批准号:2837837
-
项目类别:
-
资助金额:$7.84万
-
财政年份:1998
-
负责人:JOHN L. MARSHALL
-
依托单位:
PKC MODULATION IN PATIENTS WITH ADVANCED CANCER
-
批准号:2010206
-
项目类别:
-
资助金额:$19.81万
-
财政年份:1996
-
负责人:JOHN L. MARSHALL
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: